World-class, locally developed - Australia’s largest annual biotech week kicks off


Record numbers of life science delegates attend AusBiotech 2022; strong line-up at AusBioInvest 2022 held in the same week.

Held this year in Perth from 26-28 October, Australia’s ‘biggest week in biotech’ includes AusBiotech 2022, Australia’s largest life science conference attracting more than 1,000 registered attendees, and AusBioInvest, the sector’s premier investment conference with more than 300 registered.

The events will feature a wide range of national and international experts and keynote speakers.

Running for more than 37 years, AusBiotech 2022 has featured an industry-led programme of more than 160 thought leaders across over 40 sessions that inspire, inform, engage and enhance the biotech community.

It also gives companies a valuable opportunity to meet and connect, creating opportunities to access funding and partnerships to enable the development of world-class therapies, diagnostics and medical devices.

Key highlights include: Professor Fiona Wood AM, Director, Burns Service of WA and Director, Burn Injury Research Unit UWA who will share her story about the revolutionary spray-on skin cells treatment, used to treat burns victims of the Bali Bombings; Professor Marvin Caruthers, Distinguished Professor from the University of Colorado who will share his insights on the biotechnology industry transformation through ground-breaking DNA synthesis chemistry; and Elizabeth Koff AM, Managing Director, Telstra Health who will talk about realising the full potential of our Australian health system.

AusBioInvest 2022, the largest investment and partnering conference in the Australian life sciences sector, facilitates meaningful connections between businesses and investors, enabling great ideas to get the funding they need. This year’s programme features informative and insightful presentations from global venture capital and investment experts in addition to the 29 Australian biotech companies, spanning early- to late-stage, that are actively seeking investors or partners to support their funding and co-development.

Highlights include presentations from Australian ex-pats Dr Arjun Goyal, Co-Founder and Managing Director of US-based life sciences VC firm Vida Ventures, and Dr Nilay Thakar, Principal at global VC fund ARCH Venture Partners. They will share their perspectives on emerging funding models and strategies for capital raising and provide their expertise on matching appropriate sources of capital to a company's point on the development pathway.

In addition, the Australian Securities Exchange (ASX) General Manager, Listings, James Posnett, joins AusBioInvest 2022 to provide up-to-date market analysis, including opportunities and headwinds for Australian life sciences.

The Government of Western Australia has embraced the opportunity with three ministers in attendance. The Deputy Premier of Western Australia, Hon Roger Cook MLA, will speak at the conference’s Welcome Reception; the Minister for Innovation and ICT; Medical Research; Emergency Services; Volunteering, Hon Stephen Dawson MLC will join AusBiotech CEO Lorraine Chiroiu to open AusBiotech 2022; and the Hon Amber-Jade Sanderson MLA will introduce the Plenary on the final day. Western Australia’s Chief Scientist Professor Peter Klinken was also present.

AusBiotech 2022 and AusBioInvest 2022 are proudly supported by their Host State Partners, the Western Australian Government and Business Events Perth.  

For more information about AusBiotech 2022 see the programme here, and for AusBioInvest 2022 see the programme here.